Why the study?
Does the creation of a subxiphoid pericardial window effectively treat pericardial effusion in patients with lung cancer?
Population
51 patients with pericardial effusion secondary to lung cancer treated between 1978 and 1990 at the National…
Design
Case_series
Authors
Loading...
May support pericardial window as palliative option in lung cancer; leaves open need for prospective trials given case-report evidence.
Does the creation of a subxiphoid pericardial window effectively treat pericardial effusion in patients with lung cancer?
Creation of a subxiphoid pericardial window is an effective palliative treatment for pericardial effusion secondary to lung cancer, though overall prognosis remains poor due to advanced underlying disease.
Okamoto et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: